MetaCap

Hims & Hers Health Inc. Class A (HIMS)

NYSE: HIMSHealth CareMedical/Nursing ServicesUSD

14.60-1.42 (-8.86%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

HIMS stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$0.83
52-week range
13.74 – 40.99
Day range
14.51 – 15.96
Volume / Avg
16.06M / 11.95M
Beta
—

52-week range

$13.74$40.99

HIMS stock today

On Nov 20, HIMS ended the session at $14.60, shedding $1.42 (8.86%), versus the S&P 500's 3.70% decline. Shares are 64.4% below their 52-week high of $40.99, set on Dec 5, 2025 and 6.3% above the 52-week low of $13.74, near the bottom of the past year's range. HIMS is down 55.0% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 57.9%.

Hims & Hers Health has posted a net loss over the last twelve months (EPS of -$0.83), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Hims & Hers Health

Company profile

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.

Industry
Medical/Nursing Services
CEO
Mr. Andrew Dudum
Headquarters
San Francisco, CA
Employees
2,442
IPO year
2019
Website
hims.com

Financial highlights

Full financials

In fiscal 2025, Hims & Hers Health generated $2.35 billion in revenue, up 59.0% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $128.4 million (+1.8% year over year), for a net margin of 5.5% versus a median of -12.2% in the prior 5 years. Gross margin was 73.8% (down from 79.5%) and operating margin 4.5%.

Hims & Hers Health annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$2.35B$1.48B$872.00M$526.92M$271.88M
Growth+59.00%+69.33%+65.49%+93.81%+82.77%
Net income$128.37M$126.04M$-23.55M$-65.68M$-107.66M
EPS (diluted)$0.51$0.53$-0.11$-0.32$-0.58

Analyst forecast

Forecast

Consensus (15 analysts)

hold

Avg. price target

$27.23+86.51%

  • Strong buy 3
  • Buy 1
  • Hold 11
  • Sell 0
  • Strong sell 0

Target range

Low $21.00High $40.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 9, 2026
EPS actual vs est.
$0.06 vs $0.07
Surprise
-14.29%

HIMS news

All HIMS news

Hims & Hers Health peers

Health Care sector
HIMS peer companies
CompanyPrice% ChgMarket capCompare
PRVAPrivia Health Group Inc.25.05+1.46%$3.20Bvs HIMS
AVAHAveanna Healthcare Holdings Inc.11.01+2.90%$2.40Bvs HIMS
ADUSAddus HomeCare Corporation122.50+1.18%$2.28Bvs HIMS
OPCHOption Care Health Inc.31.59-0.06%$4.73Bvs HIMS
LFSTLifeStance Health Group Inc.13.82+3.60%$5.25Bvs HIMS
USPHU.S. Physical Therapy Inc.95.93+1.71%$1.43Bvs HIMS
WGSGeneDx Holdings Corp. Class A45.46-7.68%$1.36Bvs HIMS
TDOCTeladoc Health Inc.7.45-4.36%$1.36Bvs HIMS

Indexes, lists and sector

Hims & Hers Health stock FAQ

What is Hims & Hers Health's stock price today?

HIMS last traded at $14.60 as of Nov 20, 4:00 PM EST, down 8.86% on the day. Prices are delayed at least 15 minutes.

Who is Hims & Hers Health's CEO?

Mr. Andrew Dudum is the chief executive officer of Hims & Hers Health Inc. Class A, which has about 2,442 employees.

What is the HIMS 52-week high?

The 52-week high for HIMS is $40.99 and the 52-week low is $13.74. The stock is currently 64.4% below its high.

Compare HIMS